Millipore Sigma Vibrant Logo

AGX806 2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6)

View This Product on Sigma-Aldrich
AGX806
1 mg  
価格を検索中…
価格が見つかりません
Minimum Quantity needs to be mulitiple of
Maximum Quantity is
弊社照会 詳細を表示 
値引
()
 
弊社照会
現在国内在庫なし
現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

       

      お問合せください

      概要

      Replacement Information
      Description
      Catalogue NumberAGX806
      Description2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6)
      Alternate Names
      • SARS-CoV
      • SARS-CoV-2
      Background InformationCoronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 nucleocapsid antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).
      References
      Product Information
      FormatPurified
      PresentationPurified protein in 10 mM Phosphate buffer, 150 mM NaCl with no preservatives, pH 7.4.
      Quality LevelMQ100
      Applications
      ApplicationThis E. coli recombinant protein 2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6), Cat. No. AGX806 is tested for use in Lateral Flow Assay.
      Key Applications
      • Immunodiffusion
      Application NotesOther recommended antigen products for lateral flow application are AGX804 or AGX808.
      Biological Information
      CloneN/A
      ConcentrationPlease refer to guidance on suggested starting dilutions and/or titers per application and sample type.
      SpecificitySARS-CoV-2
      Purification MethodColumn Purification
      UniProt Number
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at -20°C from date of receipt. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles.
      Packaging Information
      Material Size1 mg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      AGX806 04061842457885

      Documentation

      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6) (M)SDS

      タイトル

      英語版製品安全データシート((M)SDS) 

      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6) 試験成績書(CoA)

      タイトルロット番号
      2019-nCoV Nucleocapsid Recombinant Antigen, full length (Ag-6) - 3590411 3590411
      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6) - 3601705 3601705
      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6) - 3608667 3608667
      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6) - 3693111 3693111
      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6) - 3694756 3694756
      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6) - 3701839 3701839
      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6) - 3780592 3780592
      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6) - 3788633 3788633
      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6) - 3788636 3788636
      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6) - 3821522 3821522